Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
Jianguo Wen, Yongdong Feng, Wanting Huang, Haiyun Chen, Bing Liao, Lawrence Rice, Hector A. Preti, Rammurti T. Kamble, Youli Zu, Douglas J. Ballon, Chung Che Chang
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition'. Together they form a unique fingerprint.